Hennion & Walsh Asset Management, Inc. Enanta Pharmaceuticals Inc Transaction History

Hennion & Walsh Asset Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$10.08 - $17.46 $20,784 - $36,002	-2,062 Reduced 13.09%	13,689 $239,000
Q4 2023 Jan 10, 2024	SELL	$8.18 - $10.78 $100,474 - $132,410	-12,283 Reduced 43.81%	15,751 $148,000
Q3 2023 Oct 27, 2023	SELL	$11.09 - $22.13 $26,394 - $52,669	-2,380 Reduced 7.83%	28,034 $313,000
Q2 2023 Aug 09, 2023	SELL	$20.68 - $39.85 $3,412 - $6,575	-165 Reduced 0.54%	30,414 $651,000
Q1 2023 Apr 20, 2023	SELL	$38.82 - $54.59 $29,115 - $40,942	-750 Reduced 2.39%	30,579 $1.24 Million
Q4 2022 Jan 12, 2023	SELL	$40.77 - $53.73 $1.59 Million - $2.1 Million	-38,995 Reduced 55.45%	31,329 $1.46 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $342,665 - $505,731	-7,096 Reduced 9.17%	70,324 $3.65 Million
Q2 2022 Jul 19, 2022	SELL	$38.13 - $76.93 $1.03 Million - $2.08 Million	-27,074 Reduced 25.91%	77,420 $3.66 Million
Q1 2022 Apr 26, 2022	BUY	$56.06 - $74.11 $136,225 - $180,087	2,430 Added 2.38%	104,494 $7.44 Million
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $1.09 Million - $1.77 Million	-18,176 Reduced 15.12%	102,064 $7.63 Million
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $169,822 - $242,811	-4,140 Reduced 3.33%	120,240 $6.83 Million
Q2 2021 Aug 13, 2021	BUY	$43.76 - $53.11 $456,854 - $554,468	10,440 Added 9.16%	124,380 $5.47 Million
Q1 2021 May 17, 2021	BUY	$41.69 - $54.95 $4.75 Million - $6.26 Million	113,940 New	113,940 $5.62 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.